当前位置:首页 - 行情中心 - 基蛋生物(603387) - 财务分析 - 现金流量表

基蛋生物

(603387)

  

流通市值:42.20亿  总市值:42.20亿
流通股本:5.07亿   总股本:5.07亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金826,670,056.41530,229,843.98257,759,724.661,332,123,995.76
  收到的税费返还2,468,170.46849,799.74847,823.199,666,506.44
  收到其他与经营活动有关的现金39,663,969.6529,309,721.319,482,736.6852,413,814.43
  经营活动现金流入小计868,802,196.52560,389,365.03268,090,284.531,394,204,316.63
  购买商品、接受劳务支付的现金148,692,859.2773,808,358.5234,212,792.59249,022,932.31
  支付给职工以及为职工支付的现金272,603,434.73190,730,779.28117,192,677.27396,590,582.21
  支付的各项税费70,969,694.2654,723,103.5321,743,147.54100,915,126.78
  支付其他与经营活动有关的现金141,243,795.6793,941,087.2846,087,916.79224,677,619.51
  经营活动现金流出小计633,509,783.93413,203,328.61219,236,534.19971,206,260.81
  经营活动产生的现金流量净额235,292,412.59147,186,036.4248,853,750.34422,998,055.82
二、投资活动产生的现金流量:
  收回投资收到的现金410,179,969.08321,057,511.35143,290,212.96744,978,159.38
  取得投资收益收到的现金23,772,579.6310,980,362.626,638,305.8628,784,403.2
  处置固定资产、无形资产和其他长期资产收回的现金净额402,371.09234,222.65150,0005,250,735.8
  处置子公司及其他营业单位收到的现金净额779,063.58779,063.58-1,576,703.75
  投资活动现金流入小计435,133,983.38333,051,160.2150,078,518.82780,590,002.13
  购建固定资产、无形资产和其他长期资产支付的现金119,519,789.7385,183,922.7346,490,321.64156,401,671.5
  投资支付的现金460,520,525.51360,930,240247,535,688.18898,053,399.82
  取得子公司及其他营业单位支付的现金1,573,272.511,573,272.51--
  支付其他与投资活动有关的现金35,922,719.136,482,719.1-74,253,121.34
  投资活动现金流出小计617,536,306.85484,170,154.34294,026,009.821,128,708,192.66
  投资活动产生的现金流量净额-182,402,323.47-151,118,994.14-143,947,491-348,118,190.53
三、筹资活动产生的现金流量:
  吸收投资收到的现金-30,240--
  取得借款收到的现金711,000,000689,408,028.66485,000,0001,069,878,531.4
  筹资活动现金流入小计711,000,000689,438,268.66485,000,0001,069,878,531.4
  偿还债务支付的现金666,200,000586,200,000463,000,0001,148,576,001.62
  分配股利、利润或偿付利息支付的现金98,823,729.6650,510,131.212,069,613.8115,879,362.74
  其中:子公司支付给少数股东的股利、利润---4,900,000
  支付其他与筹资活动有关的现金1,134,826.89939,584.35438,828.8919,088,655.03
  筹资活动现金流出小计766,158,556.55637,649,715.56465,508,442.691,283,544,019.39
  筹资活动产生的现金流量净额-55,158,556.5551,788,553.119,491,557.31-213,665,487.99
四、汇率变动对现金及现金等价物的影响-3,055,119.05-496,657.21-85,746.955,892,537.01
五、现金及现金等价物净增加额-5,323,586.4847,358,938.17-75,687,930.3-132,893,085.69
  加:期初现金及现金等价物余额350,282,566.24350,282,566.24350,282,566.24483,175,651.93
  期末现金及现金等价物余额344,958,979.76397,641,504.41274,594,635.94350,282,566.24
补充资料:
  净利润-102,778,791.96-229,878,784.29
  资产减值准备-3,429,714.9-41,793,091.25
  固定资产和投资性房地产折旧-37,944,641.18-77,284,957.17
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-37,944,641.18-77,284,957.17
  无形资产摊销-6,006,111.27-9,947,003.03
  长期待摊费用摊销-1,937,994.69-5,801,094.1
  处置固定资产、无形资产和其他长期资产的损失-589,649.32--1,594,616.6
  固定资产报废损失-840,720.33-5,322,809.28
  公允价值变动损失--15,721,758.28--149,352.07
  财务费用-6,821,749.42--16,045,554.49
  投资损失--1,545,195.32--1,176,689.23
  递延所得税--2,175,885.08--5,977,876.24
  其中:递延所得税资产减少--4,703,234.29--5,095,096.41
    递延所得税负债增加-2,527,349.21--882,779.83
  存货的减少-11,815,654.21-3,898,650.18
  经营性应收项目的减少--91,082,617.81-23,657,303.07
  经营性应付项目的增加-59,417,083.52-30,243,283.9
  现金的期末余额-397,641,504.41-350,282,566.24
  减:现金的期初余额-350,282,566.24-483,175,651.93
  现金及现金等价物的净增加额-47,358,938.17--132,893,085.69
公告日期2025-10-312025-08-302025-04-302025-04-30
审计意见(境内)保留意见
TOP↑